74/100 B+ · Elevated risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

FITZBIONICS LIMITED

Active Private Limited Company 📍 godalming 75000 Active for 18 years

Private Limited Company · RC 06582680 · Active since 2008

B+

Overview

FITZBIONICS LIMITED is a Private Limited Company registered in GODALMING, United Kingdom, since 2008. The company operates in the 75000 sector. Its TraceComp score of 74 (B+) indicates moderate risk with some areas to watch. With 18 years of operations, the company has an established track record in its market.

Company Information

Registration Number
06582680
Legal Form
Private Limited Company
Registered
2008-05-01
Address
godalming, GU7 2QQ

Financial Profile

Latest filed accounts: FY 2025

Revenue (2025)
Net Income
Total Assets 205,444 GBP
Altman Z -0.90 distress

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

No officers on record.

Patent Portfolio

Active patent holder. 8 patents · 8 active · 8 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Current ratio 0.02 (below 1) — short-term liabilities exceed current assets
  • Altman Z-Score in the distress zone — elevated insolvency risk on the model

Similar Companies

Data Sources & Freshness

Data sourced from: bulk register.